Meckelein B, Nikiforov T, Clemen A, Appelhans H
Institute für Biochemie, Technische Hochschule Darmstadt, FRG.
Protein Eng. 1990 Jan;3(3):215-20. doi: 10.1093/protein/3.3.215.
Human mucus proteinase inhibitor (MPI) consists of 107 amino acids arranged in two domains showing high homology to each other. This protein is an inhibitor of different serine proteinases including trypsin, chymotrypsin, leukocyte elastase and cathepsin G. On the basis of sequence comparisons it has been suggested that the first domain inhibits trypsin, whereas the second one was thought to be active against chymotrypsin and elastase. To prove the location of the different inhibitory activities gene fragments for both domains have been cloned separately and expressed in Escherichia coli. Inhibition assays with the isolated recombinant domains showed that the second domain is active against chymotrypsin, neutrophil elastase and trypsin, whereas for the first domain only a weak activity against trypsin could be detected. These results suggest that the inhibitory activities of the native molecule towards these three proteinases are all located in the second domain.
人黏液蛋白酶抑制剂(MPI)由107个氨基酸组成,排列成两个彼此具有高度同源性的结构域。这种蛋白质是包括胰蛋白酶、胰凝乳蛋白酶、白细胞弹性蛋白酶和组织蛋白酶G在内的不同丝氨酸蛋白酶的抑制剂。基于序列比较,有人提出第一个结构域抑制胰蛋白酶,而第二个结构域被认为对胰凝乳蛋白酶和弹性蛋白酶有活性。为了证明不同抑制活性的位置,已分别克隆了两个结构域的基因片段并在大肠杆菌中表达。对分离出的重组结构域进行的抑制试验表明,第二个结构域对胰凝乳蛋白酶、中性粒细胞弹性蛋白酶和胰蛋白酶有活性,而对于第一个结构域,仅检测到对胰蛋白酶的微弱活性。这些结果表明,天然分子对这三种蛋白酶的抑制活性都位于第二个结构域。